Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 2
1955 1
1958 1
1959 2
1960 2
1962 1
1964 2
1965 1
1966 1
1971 2
1972 5
1973 3
1974 5
1975 4
1976 2
1977 5
1978 5
1979 4
1980 4
1981 4
1982 4
1983 2
1984 7
1985 5
1986 2
1987 1
1988 3
1989 1
1990 5
1991 3
1994 4
1995 3
1996 1
1998 3
1999 1
2000 2
2002 1
2003 2
2004 5
2005 8
2006 11
2007 13
2008 6
2009 6
2010 8
2011 4
2012 9
2013 7
2014 13
2015 10
2016 7
2017 10
2018 6
2019 12
2020 18
2021 22
2022 23
2023 26
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

308 results

Results by year

Filters applied: . Clear all
Page 1
Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus.
Werth VP, Furie RA, Romero-Diaz J, Navarra S, Kalunian K, van Vollenhoven RF, Nyberg F, Kaffenberger BH, Sheikh SZ, Radunovic G, Huang X, Clark G, Carroll H, Naik H, Gaudreault F, Meyers A, Barbey C, Musselli C, Franchimont N; LILAC Trial Investigators. Werth VP, et al. N Engl J Med. 2022 Jul 28;387(4):321-331. doi: 10.1056/NEJMoa2118024. N Engl J Med. 2022. PMID: 35939578 Clinical Trial.
Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus.
Furie RA, van Vollenhoven RF, Kalunian K, Navarra S, Romero-Diaz J, Werth VP, Huang X, Clark G, Carroll H, Meyers A, Musselli C, Barbey C, Franchimont N; LILAC Trial Investigators. Furie RA, et al. N Engl J Med. 2022 Sep 8;387(10):894-904. doi: 10.1056/NEJMoa2118025. N Engl J Med. 2022. PMID: 36069871 Clinical Trial.
Olokizumab versus Placebo or Adalimumab in Rheumatoid Arthritis.
Smolen JS, Feist E, Fatenejad S, Grishin SA, Korneva EV, Nasonov EL, Samsonov MY, Fleischmann RM; CREDO2 Group. Smolen JS, et al. N Engl J Med. 2022 Aug 25;387(8):715-726. doi: 10.1056/NEJMoa2201302. N Engl J Med. 2022. PMID: 36001712 Clinical Trial.
Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial.
Fleischmann R, Mysler E, Hall S, Kivitz AJ, Moots RJ, Luo Z, DeMasi R, Soma K, Zhang R, Takiya L, Tatulych S, Mojcik C, Krishnaswami S, Menon S, Smolen JS; ORAL Strategy investigators. Fleischmann R, et al. Lancet. 2017 Jul 29;390(10093):457-468. doi: 10.1016/S0140-6736(17)31618-5. Epub 2017 Jun 16. Lancet. 2017. PMID: 28629665 Clinical Trial.
Antimicrobial Compounds in Wine.
Todorov SD, Alves VF, Popov I, Weeks R, Pinto UM, Petrov N, Ivanova IV, Chikindas ML. Todorov SD, et al. Probiotics Antimicrob Proteins. 2023 Oct 19. doi: 10.1007/s12602-023-10177-0. Online ahead of print. Probiotics Antimicrob Proteins. 2023. PMID: 37855943 Review.
Bacillus spore-forming probiotics: benefits with concerns?
Todorov SD, Ivanova IV, Popov I, Weeks R, Chikindas ML. Todorov SD, et al. Crit Rev Microbiol. 2022 Aug;48(4):513-530. doi: 10.1080/1040841X.2021.1983517. Epub 2021 Oct 8. Crit Rev Microbiol. 2022. PMID: 34620036 Review.
Role of the lactobacilli in food bio-decontamination: Friends with benefits.
Zoghi A, Massoud R, Todorov SD, Chikindas ML, Popov I, Smith S, Khosravi-Darani K. Zoghi A, et al. Among authors: todorov sd. Enzyme Microb Technol. 2021 Oct;150:109861. doi: 10.1016/j.enzmictec.2021.109861. Epub 2021 Jun 27. Enzyme Microb Technol. 2021. PMID: 34489020 Review.
308 results